BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kouloulias V, Zygogianni A, Kypraiou E, Georgakopoulos J, Thrapsanioti Z, Beli I, Mosa E, Psyrri A, Antypas C, Armbilia C, Tolia M, Platoni K, Papadimitriou C, Arkadopoulos N, Gennatas C, Zografos G, Kyrgias G, Dilvoi M, Patatoucas G, Kelekis N, Kouvaris J. Adjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancer. World J Clin Cases 2014; 2(11): 705-710 [PMID: 25405195 DOI: 10.12998/wjcc.v2.i11.705]
URL: https://www.wjgnet.com/2307-8960/full/v2/i11/705.htm
Number Citing Articles
1
Suzanne B Evans, James B Yu. Hypofractionated Radiation Therapy Versus Conventionally Fractionated Radiation Therapy for Early-Stage Breast Cancer: How do We Choose?Future Oncology 2015; 11(15): 2105 doi: 10.2217/fon.15.130
2
Joshua T. Dilworth, Kent A. Griffith, Lori J. Pierce, Reshma Jagsi, Thomas J. Quinn, Eleanor M. Walker, Jeffrey D. Radawski, Michael M. Dominello, Greg S. Gustafson, Jean M. Moran, James A. Hayman, Frank A. Vicini. The Impact of Chemotherapy on Toxic Effects and Cosmetic Outcome in Patients Receiving Whole Breast Irradiation: An Analysis Within a Statewide Quality ConsortiumInternational Journal of Radiation Oncology*Biology*Physics 2022; 113(2): 266 doi: 10.1016/j.ijrobp.2022.02.004
3
Raouia Ben Amor, Meriem Bohli, Zeineb Naimi, Dorra Aissaoui, Nesrine Mejri, Jamel Yahyaoui, Awatef Hamdoun, Lotfi Kochbati. Hypofractionated radiotherapy after breast-conserving surgery: Clinical and dosimetric factors predictive of acute skin toxicityStrahlentherapie und Onkologie 2023; 199(1): 48 doi: 10.1007/s00066-022-01985-4
4
Grazia Lazzari, Ilaria Benevento, Antonietta Montagna, Barbara D'Andrea, Giuseppina De Marco, Giovanni Castaldo, Antonella Bianculli, Raffaele Tucciariello, Vito Metallo, Angela Solazzo. Breast Cancer Adjuvant Radiotherapy in Up-Front to Chemotherapy: Is There a Worthwhile Benefit? A Preliminary ReportBreast Cancer: Targets and Therapy 2024; : 359 doi: 10.2147/BCTT.S471345
5
Grazia Lazzari, Antonietta Montagna, Barbara D’Andrea, Antonella Bianculli, Giovanni Calice, Raffaele Tucciariello, Giovanni Castaldo, Vito Metallo, Giuseppina De Marco, Ilaria Benevento. Breast Cancer Adjuvant Radiotherapy and Chemotherapy Sequencing: Sequential, Concomitant, or What Else? A Comprehensive Review of the Adjuvant Combinations JourneyJournal of Clinical Medicine 2024; 13(20): 6251 doi: 10.3390/jcm13206251
6
Jinling Dong, Ya Yang, Dan Han, Qian Zhao, Chengxin Liu, Hongfu Sun, Zhongtang Wang, Haiqun Lin, Wei Huang. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and AnalysisTechnology in Cancer Research & Treatment 2021; 20 doi: 10.1177/15330338211064719
7
Jean L. Wright, Cristiane Takita, Isildinha M. Reis, Wei Zhao, Eunkyung Lee, Omar L. Nelson, Jennifer J. Hu. Prospective evaluation of radiation‐induced skin toxicity in a race/ethnically diverse breast cancer populationCancer Medicine 2016; 5(3): 454 doi: 10.1002/cam4.608
8
M.C. De Santis, F. Bonfantini, F. Di Salvo, M. Dispinzieri, E. Mantero, F. Soncini, P. Baili, M. Sant, G. Bianchi, C. Maggi, S. Di Cosimo, R. Agresti, E. Pignoli, R. Valdagni, L. Lozza. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapyThe Breast 2016; 29: 90 doi: 10.1016/j.breast.2016.07.013